Homocysteine and increased risk of stroke

Cardiology Review

Volumn 22, Issue 6, 2005, Pages 26-29

  Iso, Hiroyasu ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; VITAMIN B GROUP;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DATA ANALYSIS; DIET; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HOMOCYSTEINE BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE; RISK FACTOR; STROKE;

EID: 27744585926     PISSN: 10926607     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995;346 (8987):1395-1398.
2. Bostom AG, Rosenberg IH, Silbershatz H, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med. 1999;131(5):352-355.
3. Alfthan G, Pekkanen J, Jauhiainen M, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 1994;106 (1):9-19.
4. Verhoef P, Hennekens CH, Malinow MR, et al. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke. 1994;25(10):1924-1930.
5. Iso H, Rexrode K, Hennekens CH, et al. Application of computer tomography-oriented criteria for stroke subtype classification in a prospective study. Ann Epidemiol. 2000;10(2):81-87.
6. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274(19):1526-1533.
7. Stamler JS, Osborne JA, Jaraki O, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91(1):308-318.
8. Dardik R, Varon D, Tamarin I, et al. Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation. Thromb Haemost. 2000;83 (2):338-344.
9. Schreiner PJ, Wu KK, Malinow MR, et al. Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study. Ann Epidemiol. 2002;12(4):228-236.
10. Fassbender K, Mielke O, Bertsch T, et al. Homocysteine in cerebral macroangiography and microangiopathy. Lancet, 1999;353(9164):1586-1587.
11. Matsui T, Arai H, Yuzuriha T, et al. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke. 2001;32(5):1116-1119.
12. Israelsson B, Brattstrom L, Refsum H. Homocysteine in frozen plasma samples. A short cut to establish hyperhomocysteinaemia as a risk factor for arteriosclerosis? Scand J Clin Lab Invest. 1993;53(5):465-469.
13. Moriyama Y, Okamura T, Kajinami K, et al. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis. 2002;164(2):321-328.
14. Tanaka H, Iso H, Yokoyama T, et al. Cerebrovascular disease. In: Detels R, McEwen J, Beaglehole R, et al, eds. Oxford Textbook of Public Health. 4th ed. Vol 3. New York: Oxford University Press; 2001:1193-1226.
15. Malinow MR, Duell PB, Hess DL, et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folk acid in patients with coronary heart disease. N Engl J Med. 1998;338(15):1009-1015.